- Jul 30, 2007
- 8,340
- 64
- 0
- School/Org
- Newsbot U
- City
- Barre
- State
- VT
Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema (PR Newswire via Yahoo! Finance)
Published: Mon, 08 Oct 2007 12:00:00 GMT
Alimera Sciences Inc., a privately held ophthalmic pharmaceutical company, and pSivida Limited , announced today that enrollment is complete for the FAME Study of Medidur FA for the treatment of Diabetic Macular Edema.
Read More...
Published: Mon, 08 Oct 2007 12:00:00 GMT
Alimera Sciences Inc., a privately held ophthalmic pharmaceutical company, and pSivida Limited , announced today that enrollment is complete for the FAME Study of Medidur FA for the treatment of Diabetic Macular Edema.
Read More...
